Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
130 participants
INTERVENTIONAL
2007-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The best treatment of the patella during total knee arthroplasty (TKA) is controversial. The implantation of a patellar component adds to the operation time and the costs of the operation.There is a huge variation as to whether the patella is resurfaced or not during TKA. Meta-analysis of prospective, randomised trials might indicate that patellar resurfacing reduces the risk of reoperation and anterior knee pain, but drawing firm conclusions is not possible and additional, high quality randomised trials are required.
Purpose:
The aim of this study is to determine whether ther is a difference between the two groups in knee pain, functions, patient satisfaction and quality of life after TKA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patellar Resurfacing in Total Knee Arthroplasty Leads to Better Isokinetic Performance and Higher Clinical Scores
NCT04637490
Effect of Different Size of Patellar Resurfacing on Patellar Crepitus of the One-stage Bilateral Total Knee Arthroplasty.
NCT06811506
Is Partial Knee Replacement as Same-day Surgery Generalizable?
NCT04790591
Comparative Effect of Mechanical and Functional Alignment in Bilateral Total Knee Arthroplasty on Ankle Alignment
NCT06259032
Stability of Contemporary Knee Arthroplasty
NCT02861794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patellar resurfacing
Patellar component
Resurfacing with onlay technique
2
Patellar retention
No patellar component
Trimming of osteophytes when appropriate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patellar component
Resurfacing with onlay technique
No patellar component
Trimming of osteophytes when appropriate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Serious deformity (not suitable for a standard CR prosthesis)
* Patellar thickness less than 18 mm
* Prior operation involving the extensor mechanism
* Rheumatoid arthritis
* Severe medical disability limiting the ability to walk
* Revision surgery
* Knees with predominantly patellofemoral arthrosis
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sykehuset Innlandet HF
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eirik Aunan
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eirik Aunan, Doctor
Role: PRINCIPAL_INVESTIGATOR
Sykehuset Innlandet, Lillehammer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sykehuset Innlandet HF, Lillehammer
Lillehammer, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40-07172b 1.2007.952 (REK)
Identifier Type: -
Identifier Source: secondary_id
13-2007 SI (Personvernombudet)
Identifier Type: -
Identifier Source: secondary_id
aue1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.